Spotlight On Jobs Report, U.S. Auto Sales, Dollar Store Drama, And Citi TMT Conference
By Press Room
5 Mins read
Get ahead of the market by subscribing to Seeking Alpha’s Stocks to Watch, a preview of key events scheduled for the coming…
Why Warner Stocks Are A Hold Right Now: Risks And Undervaluation (NASDAQ:WBD)
By Press Room
7 Mins read
Warner Bros. Discovery (NASDAQ:WBD) stocks once again traded below $7 after weak Q2 earnings, and although it has already returned to a…
NEW YORK (August 28) – Chair Powell was surprisingly blunt in his talk last week at Jackson Hole, announcing that “the time…
Golden Ocean Group Limited 2024 Q2 - Results - Earnings Call Presentation (NASDAQ:GOGL)
By Press Room
1 Mins read
This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We…
Norwood Financial: Still On The Sidelines Despite A Solid Loan Book (NASDAQ:NWFL)
By Press Room
3 Mins read
Introduction Norwood Financial (NASDAQ:NWFL) owns the Wayne Bank in Pennsylvania. I have been keeping eyes on Norwood for a few years now,…
Sachem Capital: I Like The Risk/Reward Of The 12% Yielding Baby Bonds (NYSE:SACH)
By Press Room
4 Mins read
Introduction I have been keeping track of Sachem Capital (NYSE:SACH) for several years now as I like the REIT’s business model: it…
SES AI (NYSE:SES) continues to lead the next-gen battery manufacturers towards commercialization. SES is developing a competitive advantage with its combined hardware/software…
Alibaba: Restructuring And Investment Efforts - Bullish Support Is Growing (NYSE:BABA)
By Press Room
4 Mins read
BABA’s Reversal May Already Be Here We previously covered Alibaba Group Holding Limited (NYSE:NYSE:BABA) in April 2024, discussing the stock’s underperformance despite…
Shares of Snowflake (NYSE:SNOW) fell sharply after the cloud-focused software company reported earnings for its second fiscal quarter, which on one hand…
Ultragenyx's Strong Pipeline And Valuation Concerns: A Balanced Perspective (NASDAQ:RARE)
By Press Room
6 Mins read
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) develops innovative therapies for rare and ultra-rare genetic diseases. Its commercial portfolio includes Crysvita, Mepsevii, Dojolvi, and Evkeeza,…